Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Dizzyness

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Dizzyness in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research Excerpts

ExcerptRelevanceReference
"Primary orthostatic tremor (POT) remains a therapeutic conundrum."5.51Successful Treatment of Primary Orthostatic Tremor Using Perampanel. ( Schaefer, SM; Wadhwa, A, 2019)
"Primary orthostatic tremor (POT) remains a therapeutic conundrum."1.51Successful Treatment of Primary Orthostatic Tremor Using Perampanel. ( Schaefer, SM; Wadhwa, A, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wadhwa, A1
Schaefer, SM1

Other Studies

1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Dizzyness

ArticleYear
Successful Treatment of Primary Orthostatic Tremor Using Perampanel.
    Tremor and other hyperkinetic movements (New York, N.Y.), 2019, Volume: 9

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anticonvulsants; Clonazepam; Dizziness; Fe

2019